Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 63 citing McNagny: Prescribing hormone replacement therapy for menopausal symptoms. (0.13 sec) 

Hot flushes


V Stearns, L Ullmer, JF Lopez, Y Smith, C … - The Lancet, 2002 - Elsevier
Almost every woman and some men will encounter hot flushes during their
lifetime. Despite the prevalence of the symptoms, the pathophysiology of hot
flushes remains unknown. A decline in hormone concentrations might lead to ...
Cited by 172 - Related articles - All 8 versions

Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis


LS Phillips, RD Langer - Fertility and sterility, 2005 - Elsevier
To reconcile apparently conflicting evidence regarding the use of hormone
therapy as a health-preserving strategy in postmenopausal women in light of that
fact that findings from animal studies, human observation studies, and ...
Cited by 71 - Related articles - BL Direct - All 12 versions

Estrogen raises the sweating threshold in postmenopausal women with hot flashes* 1


RR Freedman, CM Blacker - Fertility and sterility, 2002 - Elsevier
Objective: To determine if estrogen ameliorates hot flashes by raising the core
body temperature sweating threshold, by reducing core body temperature
fluctuations, and/or by reducing sympathetic activation (as measured by ...
Cited by 54 - Related articles - BL Direct - All 15 versions

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health- …

- oxfordjournals.org [PDF] 
JV Lacey Jr, LA Brinton, MF Leitzmann, T … - JNCI Journal of the National Cancer Institute, 2006 - jnci.oxfordjournals.org
Background: Recent studies offer conflicting data on risks of ovarian cancer in
users of menopausal hormone therapy. Some findings of increased risks associated
with unopposed estrogen use are based on older studies of women with intact ...
Cited by 43 - Related articles - BL Direct - All 9 versions

Current approaches to the prevention and treatment of postmenopausal osteoporosis


SL Follin, LB Hansen - American Journal of Health-System Pharmacy, 2003 - ASHP
P HARM .D., BCPS, are Assistant Professors, Department of Pharmacy Practice and
Family Medicine, University of Colorado Health Scienc- es Center, Denver.
Address correspondence to Dr. Follin at the School of Pharmacy, University ...
Cited by 36 - Related articles - BL Direct - All 10 versions

Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief


N Panay, O Ylikorkala, DF Archer, R Gut, E … - Climacteric, 2007 - informahealthcare.com
Design A total of 577 postmenopausal women were enrolled, in three treatment
groups in a double-blind, randomized, placebo-controlled study of 0.5 mg
17β-estradiol + 0.1 mg NETA or 0.5 mg 17β-estradiol + 0.25 mg NETA or ...
Cited by 35 - Related articles - BL Direct - All 8 versions

Impact of the women's health initiative trial results on hormone replacement therapy


MB Bestul, M McCollum, LB Hansen, JJ … - Pharmacotherapy, 2004 - PPI
Megan B. Bestul, Pharm.D., Marianne McCollum, Ph.D., Laura B. Hansen, Pharm.D.,
and Joseph J. Saseen, Pharm.D., FCCP ... Study Objective. To describe the
impact of the results of the Women's Health Initiative (WHI) on hormone ...
Cited by 34 - Related articles - BL Direct - All 3 versions

The heart and estrogen/progestin replacement study revisited: hormone replacement therapy …


JA Blakely - Archives of Internal Medicine, 2000 - Am Med Assoc
Lower coronary event rates in women receiving hormone replacement therapy (HRT)
have led to a presumption of benefit. The Heart and Estrogen/Progestin
Replacement Study, a large randomized trial, observed a 1.4% first year ...
Cited by 23 - Related articles - BL Direct - All 4 versions

[PDF] Hot flashes-a review of the literature on alternative and complementary treatment …


HA Philp - Alternative Medicine Review, 2003 - thorne.com
Abstract Hot flashes are a common experience for menopausal women, with an
85-percent incidence in the West. With the increased knowledge of side effects
attributable to conventional treatment options, more women are exploring ...
Cited by 22 - Related articles - View as HTML - BL Direct - All 7 versions

Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies1


MJ Silverstein, S Parker, JC Grotting, RJ Cote … - Journal of the American College of Surgeons, 2001 - Elsevier
Presented at the American College of Surgeons 86th Annual Clinical Congress,
October 22–27, 2000, Chicago, IL. Moderator: Melvin J Silverstein, MD, FACS,
Professor of Surgery and Henrietta C Lee Chair, Keck School of Medicine, ...
Cited by 21 - Related articles - BL Direct - All 10 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google